Real-world comparative effectiveness and safety of tofacitinib and baricitinib in patients with rheumatoid arthritis

被引：0
|
作者：
Naoki Iwamoto
Shuntaro Sato
Shota Kurushima
Toru Michitsuji
Shinya Nishihata
Momoko Okamoto
Yoshika Tsuji
Yushiro Endo
Toshimasa Shimizu
Remi Sumiyoshi
Takahisa Suzuki
Akitomo Okada
Tomohiro Koga
Shin-ya Kawashiri
Keita Fujikawa
Takashi Igawa
Toshiyuki Aramaki
Kunihiro Ichinose
Mami Tamai
Hideki Nakamura
Akinari Mizokami
Tomoki Origuchi
Yukitaka Ueki
Katsumi Eguchi
Atsushi Kawakami
机构：
[1] Nagasaki University Graduate School of Biomedical Sciences,Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences
[2] Nagasaki University Hospital,Clinical Research Center
[3] Sasebo City General Hospital,Department of Rheumatology
[4] Japanese Red Cross Nagasaki Genbaku Hospital,Department of Rheumatology
[5] Nagasaki University Graduate School of Biomedical Sciences,Center for Bioinformatics and Molecular Medicine
[6] Nagasaki University Graduate School of Biomedical Sciences,Departments of Community Medicine, Division of Advanced Preventive Medical Sciences
[7] Isahaya General Hospital,Department of Rheumatology, Japan Community Healthcare Organization
[8] Sasebo Chuo Hospital,Department of Rheumatology
[9] Nagasaki University Graduate School of Biomedical Sciences,Department of Physical Therapy
来源：
Arthritis Research & Therapy | / 23卷
关键词：
Rheumatoid arthritis; Tofacitinib; Baricitinib; Comparison; Molecular-targeted therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] ADAPTABILITY, EFFECTIVENESS AND SAFETY OF TOFACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Rodriguez, Fernando
    Aza, Anggie
    Cabrera, Michael
    Santos-Moreno, Pedro
    Buitrago-Garcia, Diana
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 2154 - 2154
  • [22] Tofacitinib for the treatment of rheumatoid arthritis: a real-world study in China
    Yunzhen Shi
    Yuesheng Xie
    Guangfeng Zhang
    Yuan Feng
    [J]. Internal and Emergency Medicine, 2022, 17 : 703 - 714
  • [23] Tofacitinib: Real-World Data and Treatment Persistence in Rheumatoid Arthritis
    Bertoldi, Ilaria
    Caporali, Roberto
    [J]. OPEN ACCESS RHEUMATOLOGY-RESEARCH AND REVIEWS, 2021, 13 : 221 - 237
  • [24] EMULATING A TARGET TRIAL OF ADALIMUMAB VERSUS TOFACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS: A COMPARATIVE EFFECTIVENESS ANALYSIS USING THE OPAL REAL-WORLD DATASET
    Deakin, C.
    De Stavola, B.
    Littlejohn, G.
    Griffiths, H.
    Ciciriello, S.
    Youssef, P.
    Mathers, D.
    Bird, P.
    Smith, T.
    Osullivan, C.
    Freeman, T.
    Segelov, D.
    Hoffman, D.
    Seaman, S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 624 - 625
  • [25] Tofacitinib for the treatment of rheumatoid arthritis: a real-world study in China
    Shi, Yunzhen
    Xie, Yuesheng
    Zhang, Guangfeng
    Feng, Yuan
    [J]. INTERNAL AND EMERGENCY MEDICINE, 2022, 17 (03) : 703 - 714
  • [26] REAL-WORLD EFFECTIVENESS OF FILGOTINIB IN BELGIAN PATIENTS WITH RHEUMATOID ARTHRITIS
    Diederik, D. C.
    Durez, P.
    Lenaerts, J.
    Westhovens, R.
    Verschueren, P.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1401 - 1401
  • [27] Real-World Comparative Effectiveness of Tofacitinib and Tumor Necrosis Factor Inhibitors as Monotherapy and Combination Therapy for Treatment of Rheumatoid Arthritis
    George W. Reed
    Robert A. Gerber
    Ying Shan
    Liza Takiya
    Kimberly J. Dandreo
    David Gruben
    Joel Kremer
    Gene Wallenstein
    [J]. Rheumatology and Therapy, 2019, 6 : 573 - 586
  • [28] Real-World Comparative Effectiveness of Tofacitinib and Tumor Necrosis Factor Inhibitors as Monotherapy and Combination Therapy for Treatment of Rheumatoid Arthritis
    Reed, George W.
    Gerber, Robert A.
    Shan, Ying
    Takiya, Liza
    Dandreo, Kimberly J.
    Gruben, David
    Kremer, Joel
    Wallenstein, Gene
    [J]. RHEUMATOLOGY AND THERAPY, 2019, 6 (04) : 573 - 586
  • [29] Real-world evaluation of effectiveness, persistence, and usage patterns of tofacitinib in treatment of rheumatoid arthritis in Australia
    Bird, Paul
    Littlejohn, Geoffrey
    Butcher, Belinda
    Smith, Tegan
    Pereira, Candida da Fonseca
    Witcombe, David
    Griffiths, Hedley
    [J]. CLINICAL RHEUMATOLOGY, 2020, 39 (09) : 2545 - 2551
  • [30] Real-world evaluation of effectiveness, persistence, and usage patterns of tofacitinib in treatment of rheumatoid arthritis in Australia
    Paul Bird
    Geoffrey Littlejohn
    Belinda Butcher
    Tegan Smith
    Candida da Fonseca Pereira
    David Witcombe
    Hedley Griffiths
    [J]. Clinical Rheumatology, 2020, 39 : 2545 - 2551
12345